Dr Kevin Matthews, chief executive of (), tells Proactive they're starting to see the benefits of their March reboot to focus on polymers.
Revenues and gross profits in the first half of 2017 beat those of the same period of 2016, while the company has been successful in lowering its cost base.
The business continues to work with a number of industry players, including funded collaborations, to develop new ingredients for a range of applications in its key markets of personal and consumer health care, home care and industrial products.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Itaconix PLC named herein, including the promotion by the Company of Itaconix PLC in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HERE